Bioera announced consolidated earnings results for the year 2013. The company posted a consolidated net loss of EUR 100,000 (USD 138,600) for 2013, compared with a net profit of EUR 300,000 for 2012. Consolidated revenues rose to EUR 48.5 million from EUR 46.9 million and earnings before interest, tax, depreciation and amortisation (EBITDA) dropped to EUR 400,000 from EUR 3.9 million in 2012.

Bioera's operating line was at break-even compared with an operating profit of EUR 3.5 million booked in 2012.